Indian drugmaker Biocon Ltd. is aiming to become the world’s top supplier of insulin in the coming years, according to Bloomberg, citing co-founder Kiran Mazumdar-Shaw.
She said Biocon plans to capture growing demand for the drug as large pharmaceutical companies shift their focus to other medicines.
Biocon Aims to Become Top Global Insulin Supplier, Co-Founder Says
2026-06-16 07:34:54
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
